CANSLIM Stocks
Developed by William O'Neil of Investor's Business Daily, CANSLIM is a method of screening for stocks based on the folllowing seven characteristics. It should be noted that typically, only 2% of the database will qualify as buy candidates using these screening applications. Also, when the Market Edge "Market Posture" is bearish, there will not be any selections since the M part of the formula requires a favorable market environment. In order to qualify as a CANSLIM stock the company needs to have the following characteristics: • C=Current Earnings: Quarterly earnings per share are up 25% or more. • A=Annual Earnings: Five year average compounded earnings growth rate is greater that 24%. • N=New Highs: The stock is within 15% of making a new 52-week high and is breaking out of a period of consolodation. • S=Shares Outstanding: The number of shares outstanding is less than 50 million shares and there has been a recent increase in trading volume. • L=Leading Stocks: The company is a market leader reflected by a Relative Strength Value (RSV) of 80 or higher.A RSV of 80 means that the stock outperformed 80% of all other stocks in the data base during the past year. • I=Institutional Ownership: Institutional sponsorship should be minimal but there should be at least one major institution with a sizeable position in the stock. • M=Market Conditions: The Market Edge "Market Posture" should be Bullish.During periods when the posture is bearish, there will not be any selections.
by Saintl
S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | Exp Qtr EPS Rs. | EPS Qtr Rs. | Avg PAT 5Yrs Rs.Cr. |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
201. | Lloyds Engineeri | 79.65 | 103.36 | 9116.98 | 0.25 | 21.22 | 65.26 | 135.42 | 19.71 | 28.61 | 0.43 | 0.19 | 25.52 |
202. | Nuvoco Vistas | 353.75 | 93.07 | 12634.41 | 0.00 | 2.84 | -80.36 | 2636.48 | -6.02 | 5.42 | 0.51 | 0.08 | 163.76 |
203. | Paradeep Phosph. | 92.60 | 33.45 | 7544.86 | 0.54 | 5.38 | 104.49 | 2377.43 | -22.16 | 6.74 | 0.95 | 0.07 | 252.18 |
204. | Avalon Tech | 628.40 | 223.14 | 4150.30 | 0.00 | -2.31 | -132.67 | 199.47 | -15.15 | 6.22 | 0.18 | -0.35 | 31.94 |
205. | Astrazeneca Phar | 7731.00 | 147.53 | 19327.50 | 0.31 | -11.79 | -34.98 | 387.52 | 31.15 | 31.13 | 19.37 | -4.72 | 99.72 |
206. | UPL | 578.55 | 43426.37 | 0.17 | -527.00 | -1489.86 | 9067.00 | 1.16 | 3.29 | -6.12 | -5.12 | 2302.26 | |
207. | S H Kelkar & Co. | 323.50 | 39.57 | 4477.93 | 0.23 | -86.82 | -35.83 | 470.31 | 11.30 | 12.46 | 3.60 | -6.25 | 107.62 |
208. | Monte Carlo Fas. | 861.20 | 30.09 | 1785.43 | 2.31 | -13.27 | -14.50 | 126.00 | -9.20 | 10.63 | -0.10 | -6.40 | 87.60 |